KEGG pathway enrichment analysis results suggest that CHRNA9 may cooperate with cytokine-cytokine receptor interaction (hsa04060), transcriptional misregulation in cancer (hsa05202), proteoglycans in cancer (hsa05205), ECM-receptor interaction (hsa04512), and JAK-STAT signaling pathway (hsa04630) in glioma disease progression. Here, CHRNA9 is linked to cancer.